2Knaus WA,Zimmerman JE,Wagner DP,et al.APACHEⅡ:a severity of disease classification system.Crit Care Med,1985,13:818.
3Metz CE.Some practical issues of experimental design and analysis in radiological ROC studies.Invest Radiol,1989,24:234-245.
4Sirio CA,Tajimi K,Knaus WA,et al.An initial comparison of intensive care in Japan and the United States.Crit Care Med,1992,20:1207-1215.
5Rowan KM,Kerr JH,Major E,et al.Intensive Care Society's APACHEⅡStudy in Britain and Ireland Ⅱ:outcome comparison of intensive care units after adjustment for care mix by the American APACHEⅡ method.BMJ,1993,307:977-981.
6Oh TE,Hutchinson R,Short S,et al.Verification of the acute physiology and chronic health evaluation scoring system in a Hong Kong intensive care unit.Crit Care Med,1993,21:698.
7Cho DY,Wang YC.Comparison of the APACHEⅢ,APACHEⅡ and Glasgow Come Scale in acute head injury for prediction of mortality and functional outcome.Intensive Care Med,1997,23:77-84.
8Jialal I,Deveraj S.Inflammation and atheroselerosis:the value of the high-sensitivity C-reactive protein in assay as a risk marker[ J ].Am J Clin Pathol,2001:116(Suppl):S108-15.
7Oishi M, Mochizuki Y, Hara M, et al. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction. Clin Neuropharmacol, 1996,19 ( 6 ) :526-531.
8Tanahashi N. [ Antithrombotic therapy in cerebral infarction ]. Rin- sho Shinkeigaku ,2000,40 ( 12 ) : 1251-1253.
9Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein : clinical importance. Curr Probl Cardio1,2004,29 ( 8 ) :439493.
10Montaner J, Fernandez-Cadenas I, Molina CA, et al. Poststroke C-re- active protein is powerful prognostic tool among candidates for thrombolysis. Stroke,2006,37 (5) : 1205-1210.
